Explore the full insider trade history of Anacor Pharmaceuticals, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 5 February 2016 (Attribution). Among the most active insiders: IPPOLITO VINCENT P. All data is openly available.
21
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Anacor Pharmaceuticals, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for dermatological diseases. It is listed on NASDAQ under the ticker ANAC.